ARS Pharmaceuticals, Inc. (SPRY) Reports In-Line Q2 EPS

Go back to ARS Pharmaceuticals, Inc. (SPRY) Reports In-Line Q2 EPS
(NASDAQ: SPRY) Delayed: 4.02 -0.05 (1.23%)
Previous Close $4.07    52 Week High $ 
Open $4.08    52 Week Low $ 
Day High $4.08    P/E N/A 
Day Low $3.81    EPS $ 
Volume 2,332,021